U-Blot® Research Grade LoncastuximabCat. No. WA3100$9,999
Size: 50ug/100ug
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade LoncastuximabCat. No. WA3100
U-Blot® Research Grade LomvastomigCat. No. WA3099
U-Blot® Research Grade LomtegovimabCat. No. WA3098
U-Blot® Research Grade lofacimigCat. No. WA3097
U-Blot® Research Grade LodelcizumabCat. No. WA3096
U-Blot® Research Grade LodapolimabCat. No. WA3095
U-Blot® Research Grade LixudebartCat. No. WA3094
U-Blot® Research Grade lixarkitugCat. No. WA3093
U-Blot® Research Grade LivmoniplimabCat. No. WA3092
U-Blot® Research Grade LitifilimabCat. No. WA3091
U-Blot® Research Grade LirilumabCat. No. WA3090
U-Blot® Research Grade LirentelimabCat. No. WA3089